Latest News
Cruelly high cost of drugs in U.S.
We Americans pay more for medicines than almost any other industrialized nation in the world. here are just a few shocking examples of drug company profiteering in recent years, according, in part, to a superb 16-page report and analysis by Medscape Medical News. Imatinib (brand name Gleevec) sold by Novartis to treat chronic myelogenous leukemia, cost in 2001 about $30,000 per year. Imatinib has now tripled in price, retailing for about $90,000. Gleevec has become Novartis’s best-selling drug and brought in about $4.7 billion in 2012….Read More